Aurinia Pharmaceuticals Inc
Develops pharmaceutical products for the treatment of autoimmune diseases
Stock Performance Snapshot
Financial Health
Aurinia Pharmaceuticals is showing strong revenue and cash flow, indicating good financial performance.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring AUPH
New Opportunities in Endometriosis Treatment
This carefully selected group of biopharmaceutical stocks represents companies that could benefit from Organon's recent discontinuation of its endometriosis drug. Our analysts have identified these firms as potential leaders in addressing the significant unmet needs in women's health.
Published: July 3, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Approved therapy traction
Voclosporin’s commercial uptake is central to Aurinia’s near-term outlook; sales and reimbursement trends are worth watching, though outcomes can vary.
Pipeline and expansion
Clinical studies and potential label expansions could meaningfully change prospects, but development and regulatory risks remain.
Market and competition
Competitive immunosuppressants and payer decisions influence long-term adoption; investors should balance opportunity with typical biotech volatility.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals develops treatments for diseases including cystic fibrosis and cancer.
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals is a leading biotechnology company that develops and manufactures innovative medicines for serious medical conditions.
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics based on RNA interference (RNAi).
